Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomastine Fumarate in Williams Syndrome
NCT06315699Phase 2Completed
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clemastine in Williams syndrome, sponsored by Qilu Hospital of Shandong University. Started Mar 2024; status: completed.
02
Drugs
clemastine
03
Conditions
Williams syndrome
Beyond the preview
Go deeper on NCT06315699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06315699.